Genome-wide analysis of mRNA decay in resting and activated primary human T lymphocytes.
暂无分享,去创建一个
C. Reilly | A. Raghavan | Rachel L. Ogilvie | Michelle L Abelson | S. Raghavan | Jayprakash Vasdewani | M. Krathwohl | P. Bohjanen
[1] John D. Storey,et al. Precision and functional specificity in mRNA decay , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[2] A. Raghavan,et al. HuA and Tristetraprolin Are Induced following T Cell Activation and Display Distinct but Overlapping RNA Binding Specificities* , 2001, The Journal of Biological Chemistry.
[3] F. Granucci,et al. Gene Expression Profiling in Immune Cells Using Microarray , 2001, International Archives of Allergy and Immunology.
[4] C. Rudd,et al. CD28 signaling via VAV/SLP-76 adaptors: regulation of cytokine transcription independent of TCR ligation. , 2001, Immunity.
[5] M. Mann,et al. AU Binding Proteins Recruit the Exosome to Degrade ARE-Containing mRNAs , 2001, Cell.
[6] Andreas Rosenwald,et al. Genomic-scale measurement of mRNA turnover and the mechanisms of action of the anti-cancer drug flavopiridol , 2001, Genome Biology.
[7] Anne F. Buckley,et al. Transcription factor LKLF is sufficient to program T cell quiescence via a c-Myc–dependent pathway , 2001, Nature Immunology.
[8] C. June,et al. SAP: natural inhibitor or grand SLAM of T cell activation? , 2001, Nature Immunology.
[9] C. Akdis,et al. Mechanisms of interleukin‐10‐mediated immune suppression , 2001, Immunology.
[10] P. Tamayo,et al. Cascades of transcriptional induction during human lymphocyte activation. , 2001, European journal of cell biology.
[11] Tala Bakheet,et al. ARED: human AU-rich element-containing mRNA database reveals an unexpectedly diverse functional repertoire of encoded proteins , 2001, Nucleic Acids Res..
[12] R. Siegel,et al. The multifaceted role of Fas signaling in immune cell homeostasis and autoimmunity , 2000, Nature Immunology.
[13] I. Laird-Offringa,et al. Post-transcriptional deregulation of myc genes in lung cancer cell lines. , 2000, American journal of respiratory cell and molecular biology.
[14] M. Rowe,et al. The bfl-1 Gene Is Transcriptionally Upregulated by the Epstein-Barr Virus LMP1, and Its Expression Promotes the Survival of a Burkitt's Lymphoma Cell Line , 2000, Journal of Virology.
[15] C. Akdis,et al. IL‐10 directly acts on T cells by specifically altering the CD28 co‐stimulation pathway , 2000, European journal of immunology.
[16] R. Pardi,et al. CD28 and LFA‐1 contribute to cyclosporin A‐resistant T cell growth by stabilizing the IL‐2 mRNA through distinct signaling pathways , 2000, European journal of immunology.
[17] Y. Shimizu,et al. From the ECM to the Cytoskeleton and Back: How Integrins Orchestrate T Cell Action , 2000, Developmental immunology.
[18] R. Cuesta,et al. Control of mRNA decay by heat shock-ubiquitin-proteasome pathway. , 1999, Science.
[19] W. Zong,et al. The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-κB that blocks TNFα-induced apoptosis , 1999 .
[20] J. Wilusz,et al. ELAV proteins stabilize deadenylated intermediates in a novel in vitro mRNA deadenylation/degradation system. , 1999, Genes & development.
[21] J. Opferman,et al. What keeps a resting T cell alive? , 1999, Cold Spring Harbor symposia on quantitative biology.
[22] C Gélinas,et al. The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-kappaB that blocks TNFalpha-induced apoptosis. , 1999, Genes & development.
[23] M. Vihinen,et al. Stimulation of B and T cells activates expression of transcription and differentiation factors. , 1998, Biochemical and biophysical research communications.
[24] P. Blackshear,et al. Feedback Inhibition of Macrophage Tumor Necrosis Factor-α Production by Tristetraprolin , 1998 .
[25] A. Shyu,et al. RNA stabilization by the AU‐rich element binding protein, HuR, an ELAV protein , 1998, The EMBO journal.
[26] J. Steitz,et al. Overexpression of HuR, a nuclear–cytoplasmic shuttling protein, increases the in vivo stability of ARE‐containing mRNAs , 1998, The EMBO journal.
[27] Van der Luijt,et al. The genetic analysis of cancer , 1998, Journal of internal medicine.
[28] M. Billah,et al. Interleukin-5 mRNA stability in human T cells is regulated differently than interleukin-2, interleukin-3, interleukin-4, granulocyte/macrophage colony-stimulating factor, and interferon-gamma. , 1998, American journal of respiratory cell and molecular biology.
[29] A. Levy,et al. Hypoxic Stabilization of Vascular Endothelial Growth Factor mRNA by the RNA-binding Protein HuR* , 1998, The Journal of Biological Chemistry.
[30] P. Allavena,et al. Differential Expression of Chemokine Receptors and Chemotactic Responsiveness of Type 1 T Helper Cells (Th1s) and Th2s , 1998, The Journal of experimental medicine.
[31] P. Blackshear,et al. Feedback inhibition of macrophage tumor necrosis factor-alpha production by tristetraprolin. , 1998, Science.
[32] J. Malter,et al. Posttranscriptional regulation of mRNAs important in T cell function. , 1998, Advances in immunology.
[33] C. Y. Chen,et al. Modulation of the fate of cytoplasmic mRNA by AU-rich elements: key sequence features controlling mRNA deadenylation and decay , 1997, Molecular and cellular biology.
[34] K. McGowan,et al. Ectopic expression of Hel-N1, an RNA-binding protein, increases glucose transporter (GLUT1) expression in 3T3-L1 adipocytes , 1997, Molecular and cellular biology.
[35] D. Postma,et al. Activation of the cAMP-dependent signaling pathway downregulates the expression of interleukin-3 and granulocyte-macrophage colony-stimulating factor in activated human T lymphocytes. , 1996, Experimental hematology.
[36] S. Peltz,et al. Interrelationships of the pathways of mRNA decay and translation in eukaryotic cells. , 1996, Annual review of biochemistry.
[37] C. Y. Chen,et al. AU-rich elements: characterization and importance in mRNA degradation. , 1995, Trends in biochemical sciences.
[38] J. Ross,et al. mRNA stability in mammalian cells. , 1995, Microbiological reviews.
[39] Nick Proudfoot,et al. Expression of the early lymphocyte activation antigen CD69, a C‐type lectin, is regulated by mRNA degradation associated with AU‐rich sequence motifs , 1995, European journal of immunology.
[40] C. Thompson,et al. CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-XL. , 1995, Immunity.
[41] F. Birg,et al. CD28 costimulation up-regulates long-term IL-2R beta expression in human T cells through combined transcriptional and post-transcriptional regulation. , 1995, Journal of immunology.
[42] S. Ziegler,et al. The activation antigen CD69 , 1994, Stem cells.
[43] G. Crabtree,et al. Signal transmission between the plasma membrane and nucleus of T lymphocytes. , 1994, Annual review of biochemistry.
[44] J. Lamb,et al. CD28 mRNA rapidly decays when activated T cells are functionally anergized with specific peptide. , 1993, International immunology.
[45] J. Miller,et al. The CD28 ligand, B7, enhances IL-2 production by providing a costimulatory signal to T cells. , 1992, Journal of immunology.
[46] C. Thompson,et al. AU RNA-binding factors differ in their binding specificities and affinities. , 1992, The Journal of biological chemistry.
[47] R. Reeves,et al. Stability changes in pim-1 proto-oncogene mRNA after mitogen stimulation of normal lymphocytes. , 1991, Journal of immunology.
[48] M. Jenkins,et al. CD28 delivers a costimulatory signal involved in antigen-specific IL-2 production by human T cells. , 1991, Journal of immunology.
[49] C. Vaquero,et al. Down-regulation of lck mRNA by T cell activation involves transcriptional and post-transcriptional mechanisms. , 1991, Nucleic acids research.
[50] C. Thompson,et al. An inducible cytoplasmic factor (AU-B) binds selectively to AUUUA multimers in the 3' untranslated region of lymphokine mRNA , 1991, Molecular and cellular biology.
[51] G. Crabtree,et al. Regulation of interleukin-2 gene enhancer activity by the T cell accessory molecule CD28. , 1991, Science.
[52] J. Bishop,et al. A 3' truncation of MYC caused by chromosomal translocation in a human T-cell leukemia increases mRNA stability. , 1990, Oncogene.
[53] G. Crabtree,et al. Transmission of signals from the T lymphocyte antigen receptor to the genes responsible for cell proliferation and immune function: the missing link. , 1990, Annual review of immunology.
[54] R. Schwartz,et al. Inhibition of antigen-specific proliferation of type 1 murine T cell clones after stimulation with immobilized anti-CD3 monoclonal antibody. , 1990, Journal of immunology.
[55] C. Thompson,et al. Regulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathway. , 1989, Science.
[56] G. Crabtree. Contingent genetic regulatory events in T lymphocyte activation. , 1989, Science.
[57] I. Verma,et al. Removal of an mRNA destabilizing element correlates with the increased oncogenicity of proto-oncogene fos. , 1989, Oncogene research.
[58] John Calvin Reed,et al. Induction and regulation of CD2 mRNA in human lymphocytes. , 1988, Journal of immunology.
[59] G. Shaw,et al. A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation , 1986, Cell.
[60] T. Curran,et al. Removal of a 67-base-pair sequence in the noncoding region of protooncogene fos converts it to a transforming gene. , 1985, Proceedings of the National Academy of Sciences of the United States of America.